The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pediatric Drugs and Vaccines-Global Market Insights and Sales Trends 2024
Synopsis
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
The global Pediatric Drugs and Vaccines market size is expected to reach US$ 176440 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Drugs and Vaccines in various end use industries. The expanding demands from the Newborn, Infant and Child,, are propelling Pediatric Drugs and Vaccines market. Diphtheria, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Influenza segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Drugs and Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Drugs and Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Drugs and Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Drugs and Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Drugs and Vaccines covered in this report include Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA) and Actelion Pharmaceuticals, etc.
The global Pediatric Drugs and Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Global Pediatric Drugs and Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Drugs and Vaccines market, Segment by Type:
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Global Pediatric Drugs and Vaccines market, by Application
Newborn
Infant
Child
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pediatric Drugs and Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pediatric Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
The global Pediatric Drugs and Vaccines market size is expected to reach US$ 176440 million by 2029, growing at a CAGR of 9.0% from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Drugs and Vaccines in various end use industries. The expanding demands from the Newborn, Infant and Child,, are propelling Pediatric Drugs and Vaccines market. Diphtheria, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Influenza segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Drugs and Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Drugs and Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Drugs and Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Drugs and Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Drugs and Vaccines covered in this report include Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA) and Actelion Pharmaceuticals, etc.
The global Pediatric Drugs and Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Global Pediatric Drugs and Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Drugs and Vaccines market, Segment by Type:
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Global Pediatric Drugs and Vaccines market, by Application
Newborn
Infant
Child
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pediatric Drugs and Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pediatric Drugs and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Pediatric Drugs and Vaccines Market Overview
1.1 Pediatric Drugs and Vaccines Product Overview
1.2 Pediatric Drugs and Vaccines Market Segment by Type
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Mumps
1.2.7 Others
1.3 Global Pediatric Drugs and Vaccines Market Size by Type
1.3.1 Global Pediatric Drugs and Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Pediatric Drugs and Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pediatric Drugs and Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pediatric Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pediatric Drugs and Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pediatric Drugs and Vaccines Sales Breakdown by Type (2018-2023)
2 Global Pediatric Drugs and Vaccines Market Competition by Company
2.1 Global Top Players by Pediatric Drugs and Vaccines Sales (2018-2023)
2.2 Global Top Players by Pediatric Drugs and Vaccines Revenue (2018-2023)
2.3 Global Top Players by Pediatric Drugs and Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Pediatric Drugs and Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Drugs and Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Drugs and Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Drugs and Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Pediatric Drugs and Vaccines Market
2.8 Key Manufacturers Pediatric Drugs and Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Drugs and Vaccines Status and Outlook by Region
3.1 Global Pediatric Drugs and Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pediatric Drugs and Vaccines Historic Market Size by Region
3.2.1 Global Pediatric Drugs and Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Pediatric Drugs and Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Pediatric Drugs and Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pediatric Drugs and Vaccines Forecasted Market Size by Region
3.3.1 Global Pediatric Drugs and Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Pediatric Drugs and Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Pediatric Drugs and Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pediatric Drugs and Vaccines by Application
4.1 Pediatric Drugs and Vaccines Market Segment by Application
4.1.1 Newborn
4.1.2 Infant
4.1.3 Child
4.2 Global Pediatric Drugs and Vaccines Market Size by Application
4.2.1 Global Pediatric Drugs and Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Pediatric Drugs and Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pediatric Drugs and Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pediatric Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pediatric Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pediatric Drugs and Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pediatric Drugs and Vaccines Sales Breakdown by Application (2018-2023)
5 North America Pediatric Drugs and Vaccines by Country
5.1 North America Pediatric Drugs and Vaccines Historic Market Size by Country
5.1.1 North America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pediatric Drugs and Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Pediatric Drugs and Vaccines Sales in Value by Country (2018-2023)
5.2 North America Pediatric Drugs and Vaccines Forecasted Market Size by Country
5.2.1 North America Pediatric Drugs and Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Pediatric Drugs and Vaccines Sales in Value by Country (2024-2029)
6 Europe Pediatric Drugs and Vaccines by Country
6.1 Europe Pediatric Drugs and Vaccines Historic Market Size by Country
6.1.1 Europe Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pediatric Drugs and Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Pediatric Drugs and Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Pediatric Drugs and Vaccines Forecasted Market Size by Country
6.2.1 Europe Pediatric Drugs and Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Pediatric Drugs and Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Pediatric Drugs and Vaccines by Region
7.1 Asia-Pacific Pediatric Drugs and Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pediatric Drugs and Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pediatric Drugs and Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pediatric Drugs and Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Drugs and Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pediatric Drugs and Vaccines Sales in Value by Region (2024-2029)
8 Latin America Pediatric Drugs and Vaccines by Country
8.1 Latin America Pediatric Drugs and Vaccines Historic Market Size by Country
8.1.1 Latin America Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pediatric Drugs and Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pediatric Drugs and Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Pediatric Drugs and Vaccines Forecasted Market Size by Country
8.2.1 Latin America Pediatric Drugs and Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pediatric Drugs and Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Pediatric Drugs and Vaccines by Country
9.1 Middle East and Africa Pediatric Drugs and Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pediatric Drugs and Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pediatric Drugs and Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pediatric Drugs and Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Drugs and Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pediatric Drugs and Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co., Inc. (USA)
10.1.1 Merck & Co., Inc. (USA) Company Information
10.1.2 Merck & Co., Inc. (USA) Introduction and Business Overview
10.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
10.1.5 Merck & Co., Inc. (USA) Recent Development
10.2 Abbott Laboratories (USA)
10.2.1 Abbott Laboratories (USA) Company Information
10.2.2 Abbott Laboratories (USA) Introduction and Business Overview
10.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
10.2.5 Abbott Laboratories (USA) Recent Development
10.3 Amgen, Inc. (USA)
10.3.1 Amgen, Inc. (USA) Company Information
10.3.2 Amgen, Inc. (USA) Introduction and Business Overview
10.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
10.3.5 Amgen, Inc. (USA) Recent Development
10.4 Eli Lilly and Company (USA)
10.4.1 Eli Lilly and Company (USA) Company Information
10.4.2 Eli Lilly and Company (USA) Introduction and Business Overview
10.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
10.4.5 Eli Lilly and Company (USA) Recent Development
10.5 F. Hoffmann-La Roche Ltd (Switzerland)
10.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information
10.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
10.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
10.6 Genentech, Inc. (USA)
10.6.1 Genentech, Inc. (USA) Company Information
10.6.2 Genentech, Inc. (USA) Introduction and Business Overview
10.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
10.6.5 Genentech, Inc. (USA) Recent Development
10.7 GlaxoSmithKline plc. (UK)
10.7.1 GlaxoSmithKline plc. (UK) Company Information
10.7.2 GlaxoSmithKline plc. (UK) Introduction and Business Overview
10.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
10.7.5 GlaxoSmithKline plc. (UK) Recent Development
10.8 Janssen Biologics B.V. (USA)
10.8.1 Janssen Biologics B.V. (USA) Company Information
10.8.2 Janssen Biologics B.V. (USA) Introduction and Business Overview
10.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
10.8.5 Janssen Biologics B.V. (USA) Recent Development
10.9 Actelion Pharmaceuticals
10.9.1 Actelion Pharmaceuticals Company Information
10.9.2 Actelion Pharmaceuticals Introduction and Business Overview
10.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
10.9.5 Actelion Pharmaceuticals Recent Development
10.10 AstraZeneca Plc. (UK)
10.10.1 AstraZeneca Plc. (UK) Company Information
10.10.2 AstraZeneca Plc. (UK) Introduction and Business Overview
10.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
10.10.5 AstraZeneca Plc. (UK) Recent Development
10.11 Boehringer Ingelheim GmbH (Germany)
10.11.1 Boehringer Ingelheim GmbH (Germany) Company Information
10.11.2 Boehringer Ingelheim GmbH (Germany) Introduction and Business Overview
10.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered
10.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development
10.12 Bristol-Myers Squibb Company (USA)
10.12.1 Bristol-Myers Squibb Company (USA) Company Information
10.12.2 Bristol-Myers Squibb Company (USA) Introduction and Business Overview
10.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products Offered
10.12.5 Bristol-Myers Squibb Company (USA) Recent Development
10.13 Allergan, Inc. (USA)
10.13.1 Allergan, Inc. (USA) Company Information
10.13.2 Allergan, Inc. (USA) Introduction and Business Overview
10.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
10.13.5 Allergan, Inc. (USA) Recent Development
10.14 Novartis AG (Switzerland)
10.14.1 Novartis AG (Switzerland) Company Information
10.14.2 Novartis AG (Switzerland) Introduction and Business Overview
10.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products Offered
10.14.5 Novartis AG (Switzerland) Recent Development
10.15 Novo Nordisk A/S (Denmark)
10.15.1 Novo Nordisk A/S (Denmark) Company Information
10.15.2 Novo Nordisk A/S (Denmark) Introduction and Business Overview
10.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products Offered
10.15.5 Novo Nordisk A/S (Denmark) Recent Development
10.16 Pfizer, Inc. (USA)
10.16.1 Pfizer, Inc. (USA) Company Information
10.16.2 Pfizer, Inc. (USA) Introduction and Business Overview
10.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
10.16.5 Pfizer, Inc. (USA) Recent Development
10.17 Sanofi S.A (France)
10.17.1 Sanofi S.A (France) Company Information
10.17.2 Sanofi S.A (France) Introduction and Business Overview
10.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products Offered
10.17.5 Sanofi S.A (France) Recent Development
10.18 Shionogi Inc. (USA)
10.18.1 Shionogi Inc. (USA) Company Information
10.18.2 Shionogi Inc. (USA) Introduction and Business Overview
10.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products Offered
10.18.5 Shionogi Inc. (USA) Recent Development
10.19 Takeda
10.19.1 Takeda Company Information
10.19.2 Takeda Introduction and Business Overview
10.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Takeda Pediatric Drugs and Vaccines Products Offered
10.19.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Drugs and Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Drugs and Vaccines Industrial Chain Analysis
11.4 Pediatric Drugs and Vaccines Market Dynamics
11.4.1 Pediatric Drugs and Vaccines Industry Trends
11.4.2 Pediatric Drugs and Vaccines Market Drivers
11.4.3 Pediatric Drugs and Vaccines Market Challenges
11.4.4 Pediatric Drugs and Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Drugs and Vaccines Distributors
12.3 Pediatric Drugs and Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
